A phase II trial of sunitinib in recurrent and refractory ovarian, fallopian tube, and peritoneal carcinoma

被引：0
|
作者：
Campos, S. [1 ]
Penson, R. [2 ]
Berlin, S. [3 ]
Matulonis, U. [3 ]
Horowitz, N. [3 ]
机构：
[1] Harvard Univ, Sch Med, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA
来源：
GYNECOLOGIC ONCOLOGY | 2010年 / 116卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
306
引用
收藏
页码：S119 / S120
页数：2
相关论文
共 50 条
  • [21] Phase II trial of intraperitoneal cisplatin combined with paclitaxel in patients with ovarian, fallopian tube and primary peritoneal carcinomas
    Landrum, L.
    Mannel, R.
    McMeekin, D.
    Moore, K.
    Hyde, J.
    Walker, J.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S105 - S105
  • [22] A phase II study of chemoimmunotherapy for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube, and primary peritoneal cancers
    Schmeler, K. M.
    Vadhan-Raj, S.
    Ramirez, P. T.
    Cohen, L.
    Garcia, M. E.
    Bassett, R. I.
    Iyer, R. B.
    Mueller, P.
    Levenback, C. L.
    Wolf, J. K.
    Gershenson, D. M.
    Freedman, R. S.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S112 - S112
  • [23] Efficacy of third-line chemotherapy for recurrent ovarian, peritoneal and fallopian tube carcinoma.
    Tremblay, A
    Harel, F
    Lavoie, A
    Leblanc, R
    Ouellet, P
    Tessier, C
    Lalancette, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 488S - 488S
  • [24] Correction: Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer
    Dana M. Roque
    Eric R. Siegel
    Natalia Buza
    Stefania Bellone
    Dan-Arin Silasi
    Gloria S. Huang
    Vaagn Andikyan
    Mitchell Clark
    Masoud Azodi
    Peter E. Schwartz
    Gautam G. Rao
    Jocelyn C. Reader
    Pei Hui
    Joan R. Tymon-Rosario
    Justin Harold
    Dennis Mauricio
    Burak Zeybek
    Gulden Menderes
    Gary Altwerger
    Elena Ratner
    Alessandro D. Santin
    British Journal of Cancer, 2024, 130 : 1073 - 1073
  • [25] Randomized phase II trial of weekly ixabepilone with or without biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer
    Roque, Dana
    Siegel, Eric
    Buza, Natalia
    Bellone, Stefania
    Silasi, Dan-Arin
    Huang, Gloria
    Andikyan, Vaagn
    Clark, Mitchell
    Azodi, Masoud
    Schwartz, Peter
    Rao, Gautam
    Reader, Jocelyn
    Hui, Pei
    Tymon-Rosario, Joan
    Harold, Justin
    Mauricio, Dennis
    Zeybek, Burak
    Menderes, Gulden
    Altwerger, Gary
    Ratner, Elena
    Santin, Alessandro
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S58 - S58
  • [26] Randomized phase II trial of sorafenib alone or in combination with carboplatin/paclitaxel in women with recurrent platinum sensitive epithelial ovarian, peritoneal, or fallopian tube cancer
    Anita Schwandt
    Vivian E. von Gruenigen
    Robert M. Wenham
    Heidi Frasure
    Susan Eaton
    Nancy Fusco
    Pingfu Fu
    John J. Wright
    Afshin Dowlati
    Steven Waggoner
    Investigational New Drugs, 2014, 32 : 729 - 738
  • [27] Randomized phase II trial of sorafenib alone or in combination with carboplatin/paclitaxel in women with recurrent platinum sensitive epithelial ovarian, peritoneal, or fallopian tube cancer
    Schwandt, Anita
    von Gruenigen, Vivian E.
    Wenham, Robert M.
    Frasure, Heidi
    Eaton, Susan
    Fusco, Nancy
    Fu, Pingfu
    Wright, John J.
    Dowlati, Afshin
    Waggoner, Steven
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (04) : 729 - 738
  • [28] A phase 2 trial of oral imatinib in patients with epithelial ovarian, fallopian tube, or peritoneal carcinoma in second or greater remission
    Juretzka, M.
    Hensley, M. L.
    Tew, W.
    Konner, J.
    Aghajanian, C.
    Leitao, M.
    Iasonos, A.
    Soslow, R.
    Park, K.
    Sabbatini, P.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2008, 29 (06) : 568 - 572
  • [29] MANAGEMENT OF PERITONEAL METASTASES IN EPITHELIAL OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL CARCINOMA
    Gao, Yunong
    ANTICANCER RESEARCH, 2015, 35 (07) : 4301 - 4302
  • [30] Phase II trial of intraperitoneal cisplatin combined with intravenous paclitaxel in patients with ovarian, primary peritoneal and fallopian tube cancer
    Landrum, Lisa M.
    Hyde, Johnny, Jr.
    Mannel, Robert S.
    McMeekin, D. Scott
    Moore, Kathleen N.
    Walker, Joan L.
    GYNECOLOGIC ONCOLOGY, 2011, 122 (03) : 527 - 531
12345